Toxoplasmic lymphadenitis—clinical and serologic profile

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Outbreak of campylobacter food-poisoning in Northern Ireland

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis

Outbreak of campylobacter food-poisoning in Northern Ireland

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Atypical respiratory pathogens

Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K. Ekelund, P. Skinhøj, J. Madsen, H.B.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

A serosurvey of Orientia tsutsugamushi from patients with scrub typhus

Hydatid disease Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus P.-R. Hsueh, L.-M. Huang, P.-J.

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Prevalence of Toscana virus antibodies in residents of Croatia

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

R. Karakus, K. Caglar, C. Aybay Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Detection of specific IgM antibody in the investigation of an outbreak of pneumonia due to Legionella pneumophila serogroup 1 F. de Ory, J.M. Echevarría,

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

A case of pleurisy associated with antibodies to Rickettsia conorii

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

G.R. Davies Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Pathogenesis of catheter-related infections: lessons for new designs

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Training in infectious diseases and tropical medicine in Britain

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

Clinical infection services—the Leiden experience

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

Clinical Microbiology and Infection

Evaluation of the performance of the Helico Blot 2

Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.

A. Norberg, C.E. Nord, B. Evengård Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Carratalà J. Clinical Microbiology and Infection

N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos

J.L. Balcázar Clinical Microbiology and Infection

Typing of Clostridium difficile

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Localized Mycobacterium avium complex infection in a patient on HAART

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Toxoplasmic lymphadenitis—clinical and serologic profile R.A. Durlach, F. Kaufer, L. Carral, J. Hirt Clinical Microbiology and Infection Volume 9, Issue 7, Pages 625-631 (July 2003) DOI: 10.1046/j.1469-0691.2003.00575.x Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Age distribution. Clinical Microbiology and Infection 2003 9, 625-631DOI: (10.1046/j.1469-0691.2003.00575.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Sabin–Feldman test. Titer distribution and evolution during the six trimesters. Clinical Microbiology and Infection 2003 9, 625-631DOI: (10.1046/j.1469-0691.2003.00575.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Complement-fixation test. Titer distribution and evolution during the six trimesters. Clinical Microbiology and Infection 2003 9, 625-631DOI: (10.1046/j.1469-0691.2003.00575.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 4 IgM immunofluorescence antibody test. Titer distribution and evolution during the six trimesters. Clinical Microbiology and Infection 2003 9, 625-631DOI: (10.1046/j.1469-0691.2003.00575.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 5 IgM immunosorbent agglutination assay. Titer distribution and evolution during the six trimesters. Clinical Microbiology and Infection 2003 9, 625-631DOI: (10.1046/j.1469-0691.2003.00575.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions